Ascendis Pharma A (ASND) Cash from Operations (2014 - 2026)

Ascendis Pharma A has disclosed Cash from Operations across 13 years of filings, most recently posting 9039327.16 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 9039327.16, up 39.96% year-over-year; the trailing twelve-month figure through Mar 2026 was 138536135.97 (up 41.27% YoY), and the FY2025 annual result was 146404080.93, up 55.26% from the prior year.
• Cash from Operations came in at 9039327.16 for Q1 2026 at Ascendis Pharma A, up from 123704068.35 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 2516975.61 in Q3 2025 to a low of 166744814.28 in Q2 2023.
• The 5-year median for Cash from Operations is 99650776.84 (2022), against an average of 89028542.68.
• Across the five-year window, Cash from Operations tumbled 103.86% in 2024 and jumped 104.08% in 2025, its largest moves.
• Ascendis Pharma A's Cash from Operations stood at 143506974.16 in 2022, then surged by 68.16% to 45695167.93 in 2023, then sank by 103.86% to 93155872.6 in 2024, then sank by 32.79% to 123704068.35 in 2025, then surged by 92.69% to 9039327.16 in 2026.
• The last three Cash from Operations figures came in at 9039327.16 (Q1 2026), 123704068.35 (Q4 2025), and 2516975.61 (Q3 2025), per Business Quant data.